Physician profile
James A Betti
NPI 1457315426
$1,803.93
in general payments reported to CMS, 2019-2025
12 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.32 · 2022: $1,331 · 2023: $110 · 2024: $94.63 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,226.98 | 2022 | |
| Abbvie INC. | $131.09 | 2022-2024 | Botox |
| Sumitomo Pharma America, INC. | $101.22 | 2024-2025 | Gemtesa |
| Janssen Biotech, INC. | $78.22 | 2025 | Erleada |
| Tolmar, INC. | $40.71 | 2023 | |
| Boston Scientific Corporation | $40.06 | 2025 | Ams 700 |
| Progenics Pharmaceuticals, INC. | $39.57 | 2022-2025 | |
| Ge Healthcare | $34.61 | 2023 | |
| Ambu INC. | $34.32 | 2021 | |
| Urogen Pharma, INC. | $33.78 | 2025 | |
| Pfizer INC. | $21.78 | 2022 | |
| Telix Pharmaceuticals | $21.59 | 2024 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Betti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.